Get startedLog in
    Picture of Alligator Bioscience AB logo

    ATORX — Alligator Bioscience AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Alligator Bioscience: Grant Awarded To Phase 2/3 Trial With Mitazalimab In Biliary Tract Cancer

    Picture of Alligator Bioscience AB logoAlligator Bioscience AB
    08/09/2025 07:46
    Sept 8 (Reuters) - Alligator Bioscience AB ATORX.ST:

GRANT AWARDED TO INVESTIGATOR-INITIATED PHASE 2/3 TRIAL WITH MITAZALIMAB IN BILIARY TRACT CANCER

Source text: ID:nMFNbdRXHY

Further company coverage: ATORX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Alligator Bioscience AB

    See all news